202 related articles for article (PubMed ID: 38441982)
1.
Escobar-Salom M; Barceló IM; Rojo-Molinero E; Jordana-Lluch E; Cabot G; Oliver A; Juan C
Microbiol Spectr; 2024 Apr; 12(4):e0035824. PubMed ID: 38441982
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
3. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
[TBL] [Abstract][Full Text] [Related]
4. Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic.
Alcántar-Curiel MD; Huerta-Cedeño M; Jarillo-Quijada MD; Gayosso-Vázquez C; Fernández-Vázquez JL; Hernández-Medel ML; Zavala-Pineda M; Morales-Gil MÁ; Hernández-Guzmán VA; Bolaños-Hernández MI; Giono-Cerezo S; Santos-Preciado JI
PeerJ; 2023; 11():e15007. PubMed ID: 37013147
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of human intravenous immunoglobulin in combination with antimicrobials and human serum against multidrug-resistant isolates of Acinetobacter baumannii.
de Lima FCG; de Araújo AR; do Nascimento AV; Bezerra Cavalcanti CL; Oliveira Júnior JB; Sandes JM; da Silva EM; de Freitas CF; Veras DL; Alves LC; Brayner FA
Braz J Microbiol; 2023 Dec; 54(4):2845-2856. PubMed ID: 37904004
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of In vitro Efficacy of Meropenem/Colistin and Meropenem/Fosfomycin Combinations on Multidrug Resistant Gram-Negative Bacilli].
Adaleti R; Nakipoğlu Y; Arıcı N; Kansak N; Çalık Ş; Şenbayrak S; Balık R; Aksaray S
Mikrobiyol Bul; 2023 Jul; 57(3):365-377. PubMed ID: 37462301
[TBL] [Abstract][Full Text] [Related]
8. Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives.
Escobar-Salom M; Torrens G; Jordana-Lluch E; Oliver A; Juan C
Biol Rev Camb Philos Soc; 2022 Jun; 97(3):1005-1037. PubMed ID: 35043558
[TBL] [Abstract][Full Text] [Related]
9. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
Vidaillac C; Benichou L; Duval RE
Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of human defensins against
Bolatchiev A
PeerJ; 2020; 8():e10455. PubMed ID: 33304659
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of susceptibility of gram-positive and -negative bacteria to human defensins by using radial diffusion assay.
Takemura H; Kaku M; Kohno S; Hirakata Y; Tanaka H; Yoshida R; Tomono K; Koga H; Wada A; Hirayama T; Kamihira S
Antimicrob Agents Chemother; 1996 Oct; 40(10):2280-4. PubMed ID: 8891130
[TBL] [Abstract][Full Text] [Related]
12. Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin.
Personne Y; Curtis MA; Wareham DW; Waite RD
J Antimicrob Chemother; 2014 Dec; 69(12):3236-43. PubMed ID: 25134721
[TBL] [Abstract][Full Text] [Related]
13. PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens.
Euler CW; Raz A; Hernandez A; Serrano A; Xu S; Andersson M; Zou G; Zhang Y; Fischetti VA; Li J
Antimicrob Agents Chemother; 2023 May; 67(5):e0151922. PubMed ID: 37098944
[TBL] [Abstract][Full Text] [Related]
14. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
15. Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients.
Liang W; Liu XF; Huang J; Zhu DM; Li J; Zhang J
BMC Infect Dis; 2011 Apr; 11():109. PubMed ID: 21521536
[TBL] [Abstract][Full Text] [Related]
16. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
Kamoshida G; Yamada N; Nakamura T; Yamaguchi D; Kai D; Yamashita M; Hayashi C; Kanda N; Sakaguchi M; Morimoto H; Sawada T; Okada T; Kaya Y; Takemoto N; Yahiro K
Microbiol Spectr; 2022 Oct; 10(5):e0192822. PubMed ID: 36173297
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.
Jia P; Zhu Y; Zhang H; Cheng B; Guo P; Xu Y; Yang Q
BMC Microbiol; 2022 Oct; 22(1):234. PubMed ID: 36182895
[TBL] [Abstract][Full Text] [Related]
18. Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens.
Antonelli A; Coppi M; Tellapragada C; Hasan B; Maruri A; Gijón D; Morecchiato F; de Vogel C; Verbon A; van Wamel W; Kragh KN; Frimodt-Møller N; Cantón R; Giske CG; Rossolini GM
Int J Antimicrob Agents; 2022 Oct; 60(4):106668. PubMed ID: 36038097
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
Somily AM; Absar MM; Arshad MZ; Al Aska AI; Shakoor ZA; Fatani AJ; Siddiqui YM; Murray TS
Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309
[TBL] [Abstract][Full Text] [Related]
20. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]